(20 second reading) Strides Pharma Science informed today that its wholly-owned subsidiary, Strides Alathur Private Limited, received two observations during a routine cGMP inspection conducted by the USFDA. The inspection took place at the company’s formulations facility in Alathur, Chennai, from April 1 to April 5, 2024.

Strides Pharma Science is a global pharmaceutical company headquartered in Bangalore, India, with a focus on developing and manufacturing a wide range of IP-led niche pharmaceutical products. The company has a strong presence in the regulated markets of the United States, Europe, and Australia, as well as in emerging markets.